Lanean...
RhoGDI2 up-regulates P-glycoprotein expression via Rac1 in gastric cancer cells
Multidrug resistance (MDR) is a major clinical obstacle in treatment of gastric cancer. Previously, using 2D electrophoresis-mass spectrometry, we identified RhoGDI2 as a contributor to 5-FU resistance in colon cancer cells, and also confer gastric cancer cells resistance to 5-FU. Here, we reported...
Gorde:
| Argitaratua izan da: | Cancer Cell Int |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
BioMed Central
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4404694/ https://ncbi.nlm.nih.gov/pubmed/25901126 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-015-0190-4 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|